Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Rosen, David B."'
Publikováno v:
Case Reports in Ophthalmology. Jan-Dec2024, Vol. 15 Issue 1, p189-195. 7p.
Autor:
Grant, Stephen R., Smith, Benjamin D., Likhacheva, Anna O., Shirvani, Shervin M., Rosen, David B., Guadagnolo, B. Ashleigh, Shumway, Dean A., Holliday, Emma B., Chamberlain, Daniel, Walker, Gary V.
Publikováno v:
In Practical Radiation Oncology September-October 2018 8(5):e329-e336
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rosen, David B., Cordeiro, James A., Cohen, Aileen, Lacayo, Norman, Hogge, Donna, Hawtin, Rachael E., Cesano, Alessandra
Publikováno v:
In Leukemia Research July 2012 36(7):900-904
Autor:
Zúñiga, Luis Alejandro, Leßmann, Torben, Uppal, Karan, Bisek, Nicola, Hong, Enping, Rasmussen, Caroline E., Karlsson, Jens-Jakob, Zettler, Joachim, Holten-Andersen, Lars, Bang, Kathy, Thakar, Dhruv, Lee, Yu-Chi, Martinez, Salomon, Sabharwal, Simran Singh, Stark, Sebastian, Faltinger, Frank, Kracker, Oliver, Weisbrod, Samuel, Müller, Robin, Voigt, Tobias, Bigott, Kornelia, Tabrizifard, Mohammad, Breinholt, Vibeke Miller, Mirza, Amer M., Rosen, David B., Sprogøe, Kennett, Punnonen, Juha
Additional file 4: Figure S3. TransCon TLR7/8 Agonist inhibited MC38 tumor growth in a dose-dependent manner. Female C57BL/6 mice were SC implanted with 5 x 105 CT26 tumor cells in their flank. When tumors were grown to a mean tumor volume of ~100 mm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77845fbc0e14a68497dbf59165c449aa
Autor:
Zúñiga, Luis Alejandro, Leßmann, Torben, Uppal, Karan, Bisek, Nicola, Hong, Enping, Rasmussen, Caroline E., Karlsson, Jens-Jakob, Zettler, Joachim, Holten-Andersen, Lars, Bang, Kathy, Thakar, Dhruv, Lee, Yu-Chi, Martinez, Salomon, Sabharwal, Simran Singh, Stark, Sebastian, Faltinger, Frank, Kracker, Oliver, Weisbrod, Samuel, Müller, Robin, Voigt, Tobias, Bigott, Kornelia, Tabrizifard, Mohammad, Breinholt, Vibeke Miller, Mirza, Amer M., Rosen, David B., Sprogøe, Kennett, Punnonen, Juha
Additional file 1: Table S1A. Flow cytometry reagents for analysis of mouse blood. Table S1B. Populations analyzed in mouse blood. Table S2A. Flow cytometry reagents for analysis of antigen presenting cells from mouse tDLN and tumor cell samples. Tab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f42aa565b26ac25e4f940d0c721a756
Autor:
Zúñiga, Luis Alejandro, Leßmann, Torben, Uppal, Karan, Bisek, Nicola, Hong, Enping, Rasmussen, Caroline E., Karlsson, Jens-Jakob, Zettler, Joachim, Holten-Andersen, Lars, Bang, Kathy, Thakar, Dhruv, Lee, Yu-Chi, Martinez, Salomon, Sabharwal, Simran Singh, Stark, Sebastian, Faltinger, Frank, Kracker, Oliver, Weisbrod, Samuel, Müller, Robin, Voigt, Tobias, Bigott, Kornelia, Tabrizifard, Mohammad, Breinholt, Vibeke Miller, Mirza, Amer M., Rosen, David B., Sprogøe, Kennett, Punnonen, Juha
Additional file 3: Figure S2. TransCon TLR7/8 Agonist inhibited CT26 tumor growth in a dose-dependent manner. Female BALB/c mice were SC implanted with 3 x 105 CT26 tumor cells in their flank. When tumors were grown to a mean tumor volume of ~115 mm3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::429795e0f516ee91ecdf70f4295886d0
Autor:
Zúñiga, Luis Alejandro, Leßmann, Torben, Uppal, Karan, Bisek, Nicola, Hong, Enping, Rasmussen, Caroline E., Karlsson, Jens-Jakob, Zettler, Joachim, Holten-Andersen, Lars, Bang, Kathy, Thakar, Dhruv, Lee, Yu-Chi, Martinez, Salomon, Sabharwal, Simran Singh, Stark, Sebastian, Faltinger, Frank, Kracker, Oliver, Weisbrod, Samuel, Müller, Robin, Voigt, Tobias, Bigott, Kornelia, Tabrizifard, Mohammad, Breinholt, Vibeke Miller, Mirza, Amer M., Rosen, David B., Sprogøe, Kennett, Punnonen, Juha
Additional file 2: Figure S1. Consistent resiquimod release in vitro from TransCon TLR7/8 Agonist in the pH range between 6.8 and 7.8. A suspension of TransCon TLR7/8 Agonist (nominal 47 μg eq. of resiquimod) in 60 mM phosphate buffer was incubated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::014344b0eb0e9bf8a0cebff8243ef718
Autor:
Rosen, David B.1 (AUTHOR), Moshirfar, Majid2,3,4 (AUTHOR) cornea2020@me.com, Heiland, Madeline B.1 (AUTHOR), Ronquillo, Yasmyne C.4 (AUTHOR), Hoopes, Phillip C.4 (AUTHOR)
Publikováno v:
Ophthalmology & Therapy. Sep2019, Vol. 8 Issue 3, p353-359. 7p.